Health Condition 1: H260- Infantile and juvenile cataract
Conditions
Interventions
Intervention1: Adjunctive Intracameral Triamcinolone Acetonide: Dose- 0.03 ml (40mg/ml) Intracameral Triamcinolone acetonite
Frequency- once at the end of surgery
To compare efficacy of postoperative
Sponsors
Dr Usha Kaul Raina
Eligibility
Inclusion criteria
Inclusion criteria: Patients between 5 and 10 years of age with congenital and developmental cataract
Exclusion criteria
Exclusion criteria: Patients having active or chronic inflammation, uveitis and secondary glaucoma Family history of glaucoma High myopes Presence of any gross ocular pathology like micropthalmos, aniridia,coloboma Presence of PHPV, retinal detachment Presence of significant corneal opacity Significant systemic diseases which may make the child unfit for surgery Any subluxation of the lens
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Signs of anterior segment inflammation 1) Posterior synechiae 2) Cells/flareTimepoint: Postoperative Day 1 Week 1 week 3 Week 6 Week 12 Over period of 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Pigments deposition on IOL Pupillary membrane Posterior Capsular Opacification Intraocular pressure Central corneal thickness Cystoid macular edemaTimepoint: Postoperative Day1 1week 3week 6week 12week | — |
Countries
India
Contacts
Public ContactKumar Ravinesh
Maulana Azad medical college
Outcome results
None listed